For research use only
| Cat No. | ABC-RC004Y |
| Product Type | Reporter Stable Cell Lines |
| Cell Type | Epithelial |
| Species | Mouse |
| Host Cell | KLN205 |
| Source Organ | Lung |
| Disease | Squamous Cell Carcinoma |
| Storage | Liquid Nitrogen |
KLN205/GFP-Luciferase Stable Cell Line by AcceGen combines GFP fluorescence and luciferase bioluminescence for dual-mode tumor tracking in cancer research.
KLN205/GFP-Luciferase Stable Cell Line is a dual-reporter murine lung squamous carcinoma model engineered from KLN205 cells by stable co-expression of green fluorescent protein (GFP) and luciferase (Luc). This cell line combines optical and bioluminescent imaging capabilities, enabling both real-time fluorescence tracking and sensitive in vivo bioluminescence detection of tumor growth and metastasis. The adherent epithelial cells maintain native KLN205 characteristics including squamous carcinoma morphology and proliferative capacity, while offering dual-modal imaging for longitudinal studies. Ideal for preclinical cancer research, this cell line supports applications such as high-throughput drug screening, metastasis analysis, and treatment efficacy evaluation. Rigorous quality control confirms all cells are free of mycoplasma, fungi, yeast, and bacteria.
| Species | Mouse |
| Cat.No | ABC-RC004Y |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Lung |
| Disease | Squamous Cell Carcinoma |
| Biosafety Level | 2 |
| Storage | Liquid Nitrogen |
| Product Type | Reporter Stable Cell Lines |
| Host Cell | KLN205 |
| Gene Info | GFP / Luciferase |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
The KLN205/GFP-Luciferase Stable Cell Line is a dual-reporter system that enables complementary GFP fluorescence and luciferase bioluminescence imaging. It allows sensitive in vivo tumor tracking and cellular-level validation, making it ideal for studies of tumor growth, metastasis, and therapeutic response in murine lung squamous carcinoma models. This dual-modality system supports reliable drug screening, metastasis research, and treatment efficacy evaluation, while its non-invasive imaging capability enhances longitudinal preclinical studies of tumor biology and anticancer drug development.